iNtRON Biotechnology announced that SAL200, a endolysin-based novel antibacterial treatment for Staph superbugs including MRSA, has come back to the market and is now...
SLINGSHOT BIOSCIENCES, INC., the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use...
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that the South African Health Products Regulatory Authority (SAHPRA) granted conditional registration...
Chemomab Therapeutics Ltd., (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high...
Degron Therapeutics ("Degron"), a biotechnology company developing a new class of small-molecule medicines that target previously undruggable targets, announced research suggesting lenalidomide, a molecular...
